C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/14 (2006.01) A61K 31/42 (2006.01) A61K 31/506 (2006.01) A61P 9/00 (2006.01) A61P 35/00 (2006.01) C07D 231/52 (2006.01) C07D 261/16 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 403/14 (2006.01) C07D 405/04 (2006.01) C07D 405/14 (2006.01) C07D 409/04 (2006.01) C07D 409/14 (2006.01) C07D 413/04 (2006.01)
Patent
CA 2348847
Isoxazoles of formula (I) below have good affinity for endothelin receptors, and are selective for ET A over ET B. (see formula I) Such compounds are useful in the treatment of conditions mediated by endothelin.
Banks Bernard Joseph
Chubb Nathan Anthony Logan
Eshelby James John
Pacey Michael Stephen
Schulz Darren John
Bereskin & Parr
Pfizer Inc.
LandOfFree
New isoxazole-sulfonamide endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New isoxazole-sulfonamide endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New isoxazole-sulfonamide endothelin antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1511756